The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
Novel bispecific antibodies talquetamab and teclistamab receives positive CHMP opinions for the treatment of relapsed and refractory multiple myeloma
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)…